Phase III Insulin Add-On Asia Regional Program - ST
Clinical trial NCT02096705 · COMPLETED
Trial details
- NCT number
- NCT02096705
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-31
- Primary completion
- 2016-01-28
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.